FDA Action Update, Week of August 23, 2026: Authorization, Clinical Hold, and Clearance

The FDA was busy early this month, during the week of August 23, 2026, making a number of decisions on potential new therapeutic agents, including placing a clinical hold, extending a Prescription Drug User Fee Act (PDUFA) target action date, granting a clearance, a designation and a De Novo marketing authorization.